These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8625321)
21. The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Yamamoto H; Lamphier MS; Fujita T; Taniguchi T; Harada H Oncogene; 1994 May; 9(5):1423-8. PubMed ID: 8152803 [TBL] [Abstract][Full Text] [Related]
22. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Tanaka N; Ishihara M; Lamphier MS; Nozawa H; Matsuyama T; Mak TW; Aizawa S; Tokino T; Oren M; Taniguchi T Nature; 1996 Aug; 382(6594):816-8. PubMed ID: 8752276 [TBL] [Abstract][Full Text] [Related]
23. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. Marecki S; Atchison ML; Fenton MJ J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013 [TBL] [Abstract][Full Text] [Related]
24. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Nguyen H; Lin R; Hiscott J Oncogene; 1997 Sep; 15(12):1425-35. PubMed ID: 9333018 [TBL] [Abstract][Full Text] [Related]
25. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells. Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391 [TBL] [Abstract][Full Text] [Related]
26. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs. Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426 [TBL] [Abstract][Full Text] [Related]
27. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression. Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671 [TBL] [Abstract][Full Text] [Related]
28. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2. Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076 [TBL] [Abstract][Full Text] [Related]
29. [Functional role of IRF--family transcription factors]. Tanaka N Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1551-9. PubMed ID: 10879133 [No Abstract] [Full Text] [Related]
30. Thyroid cell transformation requires the expression of the HMGA1 proteins. Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527 [TBL] [Abstract][Full Text] [Related]
31. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1. Taniguchi T; Tanaka N; Taki S Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):43-8. PubMed ID: 9831185 [TBL] [Abstract][Full Text] [Related]
33. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2. Xi H; Goodwin B; Shepherd AT; Blanck G Oncogene; 2001 Jul; 20(31):4219-27. PubMed ID: 11464288 [TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2. Staal A; Enserink JM; Stein JL; Stein GS; van Wijnen AJ J Cell Physiol; 2000 Nov; 185(2):269-79. PubMed ID: 11025449 [TBL] [Abstract][Full Text] [Related]
35. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene. Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339 [TBL] [Abstract][Full Text] [Related]
36. IRF-1 and IRF-2 as regulators of the interferon system and cell growth. Taniguchi T Indian J Biochem Biophys; 1995 Oct; 32(5):235-9. PubMed ID: 8713742 [TBL] [Abstract][Full Text] [Related]
37. [Involvement of positive (IRF-1) and negative (IRF-2) transcription factors in the gene regulation of the type I interferon system]. Watanabe N; Taniguchi T Tanpakushitsu Kakusan Koso; 1992 Oct; 37(14 Suppl):2813-22. PubMed ID: 1438857 [No Abstract] [Full Text] [Related]
38. SUMOylated IRF-1 shows oncogenic potential by mimicking IRF-2. Park SM; Chae M; Kim BK; Seo T; Jang IS; Choi JS; Kim IC; Lee JH; Park J Biochem Biophys Res Commun; 2010 Jan; 391(1):926-30. PubMed ID: 19962964 [TBL] [Abstract][Full Text] [Related]
39. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1. Tanaka N; Ishihara M; Taniguchi T Cancer Lett; 1994 Aug; 83(1-2):191-6. PubMed ID: 8062214 [TBL] [Abstract][Full Text] [Related]
40. The complete derived amino acid sequence of human lysyl oxidase and assignment of the gene to chromosome 5 (extensive sequence homology with the murine ras recision gene). Mariani TJ; Trackman PC; Kagan HM; Eddy RL; Shows TB; Boyd CD; Deak SB Matrix; 1992 Jun; 12(3):242-8. PubMed ID: 1357535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]